Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Cantargia highlights AACR preclinical data for nadunolimab plus ras inhibition in PDAC
Cantargia said preclinical data presented at AACR supports nadunolimab combined with ras inhibition in PDAC, citing two approaches acting on non-overlapping parts of PDAC biology and impacts on the tumor microenvironment and tumor burden.